Nasal delivery of insulin using chitosan microspheres

References

• ACIKGOZ, M., KAs, H. S., ORMAN, M. and HINCAL, A. A., 1996, Chitosan microspheres of diclofenac sodium: I. application of factorial design and evaluation of release kinetics. Journal of Microencapsulation, 13, 141–160.
   Google Scholar
• AIEDEH, K., GIANASI, E., ORIENTI, I. and ZECCHI, V., 1997, Chitosan microcapsules as controlled release systems for insulin. Journal of Microencapsulation, 14, 567–576.
   PubMedGoogle Scholar
• AKBUGA, J. and BERGISADI, N., 1997, Effect of drug properties on physical and release characteristics of eudragit microspheres prepared by spherical crystallization techniques. Drug Development and Industrial Pharmacy, 23, 407–411.
   Google Scholar
• AL-HELw, A. A., AL-ANGARY, A. A., MAHROUS, G. M. and AL-DARDARI, M. M., 1998, Preparation and evaluation of sustained release cross-linked chitosan microspheres containing phenobarbitone. Journal of Microencapsulation, 15, 373–382.
   Google Scholar
• ALMEIDA, A. J., ALPAR, H. 0. and BROWN, M. R. W., 1993, Immune response to nasal delivery of antigenisity intact tetanus toxoid associated with poly (L-lactic acid) microspheres in rats, rabbits and guinea-pigs. International Journal of Pharmaceutics, 45, 198–203.
   Google Scholar
• ALPAT, H. 0. and ALMEIDA, A. J., 1994, Identification of some of the physico-chemical characteristics of microspheres which influence the induction of the immune response following mucosal delivery. European Journal of Pharmaceutics and Biopharmaceutics, 40, 198–202.
   Google Scholar
• BANAKAR, U. V., 1992, Pharmaceutical dissolution testing (New York: Marcel Dekker), pp. 192–193.
   Google Scholar
• BJORK, E. and EDMAN, P., 1988, Degradable starch microspheres as a nasal delivery system for insulin. International Journal of Pharmaceutics, 47, 233–238.
   Google Scholar
• CAHILL, E. S., CPHAGAN, D. T., ILLUM, L., BARNARD, A., MILLS, K. H. G. and REDHEAD, K., 1995, Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles. Vaccine, 13, 455–462.
   Google Scholar
• CRITCHLEY, H. S. S. D., FARRAJ, D. and ILLum, L., 1994, Nasal absorption of desmopressin in rats and in sheep. Effect of bioadhesive microsphere delivery system. Journal of Pharmaceutics and Pharmacology, 46, 651–656.
   Google Scholar
• DENKBAS, E. B., SEVYAL, M. and PISKIN, E., 1999, 5-fluorouracil loaded chitosan microspheres for chemoembolization. Journal of Microencapsulation, 16, 741–749.
   PubMedGoogle Scholar
• ELDRIDGE, J. H., STAAS, J. K., MEULBROEK, J. A., MCGHEE, J. R., TICE, T. R. and GILLEY, R. M., 1991, Biodegradable microspheres as a vaccine delivery system. Molecular Immunology, 28, 287–294.
   PubMedGoogle Scholar
• FARRAJ, N. F., JOHANSON, B. R., DAVIS, S. S. and ILLum, L., 1990, Nasal administration of insulin using bioadhesive microspheres as a delivery system. Journal of Controlled Release, 13, 253–261.
   Google Scholar
• HINCHCLIFFE, M. and ILLum, L., 1999, Intranasal insulin delivery and therapy. Advanced Drug Delivery Review, 35, 199–234.
   PubMedGoogle Scholar
• ILLum, L., 1998, Chitosan and its use as a pharmaceutical excipient. Pharmaceutical Research, 15, 1326–1331.
   PubMedGoogle Scholar
• ILLum, L., FARRAJ, N. F., CRITCHLEY, H. and DAVIS, S. S., 1988, Nasal administration of gentamycin using a novel microsphere delivey system. International Journal of Pharmaceutics, 46, 261–265.
   Google Scholar
• ILLum, L., FARRAJ, N. F. and DAVIS, S. S., 1994b, Chitosan as a novel nasal delivery system for peptide drugs. Pharmaceutical Research, 11, 1186–1189.
   PubMedGoogle Scholar
• ILLum, L., FARRAJ, N. F., DAVIS, S. S., JOHANSEN, B. R. and CPHAGAN, D. T., 1990, Investigation of the nasal absorption of biosynthetic human growth hormone in sheep-use of a bioadhesive microsphere delivery system. International Journal of Pharmaceutics, 63, 207–211.
   Google Scholar
• ILLum, L., FARRAJ, N. F., FISHER, A. N., GILL, I., MIGLIETTA, M. and BENEDETTI, L. M., 1994a, Hyaluronic acid ester microspheres as a nasal delivery system for insulin. Journal of Controlled Release, 29, 133–141.
   Google Scholar
• JAMEELA, S. R., KUMARY, T. V., LAL, A. V. and JAYAKRISHNAN, A., 1998, Progestrone-loaded chitosan microspheres: a long acting biodegradable controlled delivery system. Journal of Controlled Release, 52, 17–24.
   PubMedGoogle Scholar
• KHAN, K. A., 1975, The concept of dissolution efficiency. Journal of Pharmaceutics and Pharmacology, 27, 48–49.
   PubMed Web of Science ®Google Scholar
• KIANG, S. W., KUAN, S. S. and GUILBAULUT, G. G., 1976, Measurement of glucose in plasma, with use of immobilized glucose oxidase. Clinical Chemistry, 22, 1374–1382.
   Google Scholar
• KRIWET, B. and KISSEL, T., 1996, Poly (acrylic acid) microspheres widen intercellular spaces of Caco-2 cell monolayers: an examination by confocal laser scanning microscopy. European Journal of Pharmaceutics and Biopharmaceutics, 42, 233–240.
   Web of Science ®Google Scholar
• LACHMAN, L., LIBERMAN, H. A. and KANIG, J. L., 1986, The theory and practice of industrial pharmacy (Philadelphia: Lea and Febiger), p. 67.
   Google Scholar
• LEHR, C. M., BOUWSTRA, J. A., SCHACHT, E. H. and JUNGINGER, H. E., 1992, In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. International Journal of Pharmaceutics, 76, 43–49.
   Google Scholar
• LI, Y. P., MACHIDA, T. Y., SANNAN, T. and NAGAI, T., 1991, Preparation of chitosan microspheres containing fluorouracil using the dry-in-oil method and its release characteristics. STP Pharmaceutical Science, 1, 363–368.
   Google Scholar
• LIME, L. Y., WAN, L. S. C. and Ti, P. Y., 1997, Chitosan microspheres prepared by emulsification and ionotropic gelation. Drug Development and Industrial Pharmacy, 23, 981–985.
   Google Scholar
• MACHERAS, P., REPPAS, C. and DRESSMAN, B., 1995, Biopharmaceutics of orally administered drugs (London: Ellis Horwood), pp. 49–77.
   Google Scholar
• NAGAI, T., NISHIMOTO, Y., NAMBU, N. SuzuKI, Y. and SERKINE, K., 1984, Powder dosage form of insulin for nasal administration. Journal of Controlled Release, 1, 15–22. PERESWETOFF-MORATH, L., 1998, Microspheres as nasal drug delivery systems. Advanced
   Google Scholar
• Drug Delivery Review, 29, 185–194.
   Google Scholar
• PERESWETOFF-MORATH, L. and EDMAN, P., 1996, Immunological consequences of nasal drug delivery in dextran microspheres and ethyl (hydroxyethyl) cellulose in rats. International Journal of Pharmaceutics, 128, 23–28.
   Google Scholar
• SWITZER, R. L. and GARRITY, L. F., 1999, Experimental biochemistry (New York: W.H. Freeman and company), pp. 22–24.
   Google Scholar
• TING, T. Y., GONDA, I. and GIPPS, E. M., 1992, Microparticles of pplyvinyl alcohol for nasal delivery. I. Generation by spray-drying and spray-desolvation. Pharmaceutical Research, 9, 1330–1335.
   PubMedGoogle Scholar
• UGWOKE, M. I., VERBEKE, N. and KINGET, R., 2001, The biopharmaceutical aspects of nasal mucoadhesive drug delivery. Journal of Pharmaceutics and Pharmacology, 53, 3–22.
   PubMedGoogle Scholar
• VIDGREN, P., VIDGREN, M., ARPPE, J., HAKULI, T., LAINE, E. and PARONEN, P., 1992, In vitro evaluation of spray-dried mucoadhesive microspheres for nasal administration. Drug Development and Industrial Pharmacy, 18, 581–597.
   Google Scholar
• VIVIEN, N., BURI, P., BALANT, L. and LACROIX, S., 1994, Nasal absorption of metoclopramide administered to man. European Journal of Pharmaceutics and Biopharmaceutics, 40, 228–231.
   Google Scholar
• VYAS, S. P. BHATNAGAR, S., GOGOI, P. J. and JAIN, N. K., 1991, Preparation and characterization of HAS -propranolol microspheres for nasal administration. International Journal of Pharmaceutics, 69, 5–12.
   Google Scholar